改良儿童哮喘临床路径提升循证实践效率
本研究在三级儿童医院对已建立的儿童哮喘路径进行重大修订,包括简化视觉布局、增加循证用药推荐和实施标准化入院标准。
要点
- 路径修订后循证治疗比例提高且效果持续2年。
核心结论
- 改良现有儿童哮喘路径可持续改善循证治疗提供和患者流转,且不增加不良成本影响。
- 持续重新评估已建立的临床路径可改变提供者实践并改善患者护理。
研究设计与样本
- 研究在三级儿童医院进行,对2011年9月修订的儿童哮喘路径进行分析。
- 通过ICD-9-CM诊断代码识别病例,分析路径修订前后各24个月的数据。
- 共纳入5584例患者(修订前2928例,修订后2656例)。
- 使用统计过程控制检查护理流程变化,使用中断时间序列分析结局指标包括住院时间和成本。
主要发现
- 路径依从性在整个研究期间保持高位(79%-88%)。
- 路径修订后接受循证治疗的患者百分比提高,且结果持续2年。
关键数值与推荐
- 路径修订包括简化视觉布局、增加循证用药推荐和实施标准化入院标准。
- 路径依从性为79%-88%。
临床怎么用
- 可参考修订路径的简化布局、循证用药推荐和标准化入院标准来优化儿童哮喘管理。
- 持续重新评估已建立的临床路径可能有助于改变提供者实践并改善患者护理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In September 2011, an established pediatric asthma pathway at a tertiary care children's hospital underwent significant revision. Modifications included simplification of the visual layout, addition of evidence-based recommendations regarding medication use, and implementation of standardized admission criteria. The objective of this study was to determine the impact of the modified asthma pathway on pathway adherence, percentage of patients receiving evidence-based care, length of stay, and cost. METHODS: Cases were identified by using International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis codes. Data were analyzed for 24 months before and after pathway modification. Statistical process control was used to examine changes in processes of care, and interrupted time series was used to examine outcome measures, including length of stay and cost in the premodification and postmodification periods. RESULTS: A total of 5584 patients were included (2928 premodification; 2656 postmodification). Pathway adherence was high (79%-88%) throughout the study period. The percentage of patients receiving evidence-based care improved after pathway modification, and the results were sustained for 2 years. There was also improved efficiency, with a 30-minute (10%) decrease in emergency department length of stay for patients admitted with asthma (P = .006). There was a nominal (<10%) increase in costs of asthma care for patients in the emergency department (P = .04) and no change for those admitted to the hospital. CONCLUSIONS: Modification of an existing pediatric asthma pathway led to sustained improvement in provision of evidence-based care and patient flow without adversely affecting costs. Our results suggest that continuous re-evaluation of established clinical pathways can lead to changes in provider practices and improvements in patient care.
引用
- Rutman L, Atkins RC, Migita R, et al. Modification of an Established Pediatric Asthma Pathway Improves Evidence-Based, Efficient Care. Pediatrics. 2016. PMID: 27940683
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。